Almon Einat Brill

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
12
Insider Sells Sum
$3.37M

Insider Activity of Almon Einat Brill

The largest sale of all time was on 2012-05-02 and amounted to 166848 shares of Protalix BioTherapeutics, Inc. for $1.19M.

Biography of Almon Einat Brill

No biography is available at this moment.

2012-05-02SaleProtalix BioTherapeutics, Inc.
PLX
SVP, Product Development
166,848
0.1854%
$7.13$1.19M-20.83%
2010-10-06SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
15,000
0.0179%
$9.29$139,350-29.47%
2010-10-05SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
20,000
0.0244%
$9.08$181,600-26.26%
2010-10-04SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
35,000
0.0426%
$9.02$315,700-25.72%
2010-09-07SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
22,500
0.0277%
$8.16$183,600-14.43%
2010-09-03SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
27,500
0.0335%
$8.00$220,000-13.13%
2009-10-19SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
38,320
0.0495%
$9.43$361,358-26.21%
2009-10-16SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
23,680
0.0314%
$9.39$222,355-24.1%
2009-07-07SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
11,000
0.0144%
$4.95$54,450+40.4%
2009-07-06SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
44,000
0.0604%
$5.13$225,720+42.42%
2009-05-18SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
40,000
0.0554%
$4.00$160,000+83.38%
2008-05-12SaleProtalix BioTherapeutics, Inc.
PLX
VP, Product Development
41,427
0.0564%
$2.75$113,924-10.9%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.